MAI Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
MAI Capital Management's XBI Position: Q1 2026 in Review
MAI Capital Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 2.5% in Q1 2026, buying an estimated $117K and bringing the position to 37,960 shares worth $4.85M. The position accounts for 0.03% of the portfolio, ranked #416.
MAI Capital Management first reported a position in XBI in Q2 2015 and has held it in 38 quarters since. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- MAI Capital Management held 37,960 shares of State Street SPDR S&P Biotech ETF worth $4.85M as of Q1 2026.
- MAI Capital Management bought 941 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $117K.
- State Street SPDR S&P Biotech ETF made up 0.03% of MAI Capital Management's portfolio in Q1 2026, its #416 holding.
- MAI Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2015 and has held it in 38 quarters since.
- 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.